Platelet-rich plasma versus steroids injections for greater trochanter pain syndrome: a systematic review and meta-analysis

Filippo Migliorini,Nardeen Kader,Jörg Eschweiler,Markus Tingart,Nicola Maffulli
DOI: https://doi.org/10.1093/bmb/ldab018
2021-09-10
Abstract:Introduction: Greater trochanter pain syndrome (GTPS) is characterized by a persistent and debilitating pain around the greater trochanter. GTPS can be caused by a combination of gluteus medius or minimus tendinopathy, snapping hip or trochanteric bursitis. Source of data: Recent published literatures identified from PubMed, EMBASE, Google Scholar, Scopus. Areas of agreement: Platelet rich plasma (PRP) and corticosteroids (CCS) injections are useful options to manage symptoms of GTPS. Areas of controversy: Whether PRP leads to superior outcomes compared to CCS injections is unclear. Growing points: A systematic review and meta-analysis comparing PRP versus CCS in the management of GTPS was conducted. Areas timely for developing research: PRP injections are more effective than CCS at approximately 2 years follow-up.
What problem does this paper attempt to address?